2919
Views & Citations1919
Likes & Shares
Megalencephaly-capillary malformation syndrome
(MCAP), formerly known as macrocephaly-capillary malformation, is a rare,
complex disorder involving the skin, connective tissue, brain and other organs
that are usually present at birth. Affected individuals usually have a
disproportionately large head and capillary malformations on the skin of the
midline face, trunk and limbs. These capillary malformations often show a lacy
or reticulated pattern (resembling a net or web and are sometimes termed “cutis
marmorata”). Most children with MCAP have an enlarged brain (or
megalencephaly), in addition to other findings on brain MRI associated with
neurologic problems.
Keywords:
Megalencephaly-capillary malformation syndrome (MCAP), Mutation of the PIK3CA
gene, Phosphatidylinositol 3 kinase (PI3K), p110α
GENERALIZATIONS OF MEGALENCEPHALY-CAPILLARY
MALFORMATION SYNDROME (MCAP)
MCAP syndrome is a genetic disorder
characterized by excessive growth of various tissues in the body. Its main
features include the big brain (megalenpsy) and capillary malformations.
Multiple terms have been used in the past for this syndrome. The earliest one
was macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) because the
vascular lesions were mistakenly believed to be consistent with CMTC. However,
careful examination of the skin in these children revealed that the vascular
lesions are not CMTC but rather capillary malformations (described below) and
so the syndrome was accurately renamed to “macrocephaly-capillary malformation
syndrome” (or M-CM). Recently, the name was modified from this latter term to
“megalencephaly-capillary malformation” (or MCAP, in short) because the term
“macrocephaly” refers to a large head due various causes, whereas
“megalencephaly” is a more specific and accurate term that refers to the truly
enlarged brain present in this syndrome [1,2].
SYMPTOMS AND SINGS
OF MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME (MCAP)
People with MCAP syndrome have a head that is
larger than normal (macrospheric), which is commonly seen at birth. After
birth, the brain and the head continue to grow fast in the first few years of
life; then growth is reduced to a natural rate, although the head is larger
than the average. Excessive cerebrovascular abnormalities are common in people
with MCAP; this can include excess fluid in the brain (hydrocephalus) and
disorders in the brain structure, such as those known as chiari and
polymicrogyria abnormalities. Abnormal brain development leads to intellectual
disability in most of the affected people and can also cause seizure or poor
muscle tone (hypotonia). In particular, polymicrogyria is accompanied by a
speech delay and difficulty in chewing and swallowing [3] (Figure 1).
In some people with MCAP, excessive growth
affects not only the brain but also the rest of the body, which is known as
over-segmental growth. It can lead to an arm or leg that is larger or longer
than fingers or toes or other fingers. Some people with MCAP syndrome have a
fusion of fingers between two or more fingers or toes (cynadectal skin) [5].
The gene
involved in MCAP syndrome is also associated with a variety of cancers. Only a
small number of people with MCAP form tumors (in particular, a type of kidney
cancer called the wilms tumor and non-cancerous tumors in the nervous system
known as meningium) [7] (Figures 4 and 5).
ETIOLOGY OF
MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME (MCAP)
MCAP syndrome is caused by the mutation of
the PIK3CA gene, which is based on the long arm of chromosome number 3, at
3q26.32. This gene provides instructions for protein synthesis called p110α.
This protein is an enzyme subunit called phosphatidylinositol 3 kinase (PI3K),
which plays an important role in intracellular biochemical signaling. Signaling
PI3K is important for many cellular activities, including cell growth and
division (proliferation), cell motility (cell maturity) and cell survival.
These functions of the PIK3 enzyme are important for the development of tissues
throughout the body, including the brain and blood vessels [8] (Figures 6 and 7).
FREQUENCY OF
MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME (MCAP)
MCAP syndrome is a genetic disorder whose
frequency is not known in the world. At least 150 cases of this syndrome have
been reported in medical literature from around the world. Some patients may go
unrecognized or misdiagnosed making it difficult to determine the true
frequency of MCAP in the general population. Males and females appear to be
affected in equal numbers [10].
DIAGNOSIS OF
MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME (MCAP)
TREATMENT ROUTES FOR
MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME (MCAP)
The MCAP syndrome treatment and management
strategy is symptomatic and supportive. Treatment may be done by a team of
experts, including a neurologist, orthopedic specialist, dermatologist,
cosmetologist, surgeon and other healthcare professionals. Treatment will vary
depending upon many factors including the presence and severity of specific
abnormalities; an individual’s age and general health; and/or other elements.
Decisions concerning the use of particular interventions should be made by
physicians and other members of the health care team in careful consultation
with the patient, based upon the specifics of his or her case; a thorough
discussion of the potential benefits and risks; patient preference; and other
appropriate factors. The vascular anomalies associated with MCAP, especially if
few or small, may fade or disappear without treatment (i.e., undergo
spontaneous remission) within the first few years of life. Some patients have
undergone laser ablation therapy for lesions depending on their size, location
and extent. The appropriate management of these vascular anomalies should
therefore be discussed with child’s caring physicians. There is no definite
treatment for this syndrome and all clinical measures are needed to reduce the
suffering of the sufferers. Genetic counseling is also important for all
parents who want a healthy baby [11].
DISCUSSION AND
CONCLUSION
Megalencephaly-capillary malformation
syndrome (MCAP), formerly known as macrocephaly-capillary malformation, is a
rare, complex disorder involving the skin, connective tissue, brain and other
organs that are usually present at birth. The symptoms and severity of MCAP
vary greatly from one person to another. Some individuals may develop milder
symptoms, while others have more serious complications and it is important to
note that affected individuals may not have all of the symptoms discussed
below. Families of affected children should talk to their physician and medical
team about their specific features, associated symptoms and discuss their
medical management and overall prognosis. Most cases of MCAP are caused by
mutations in the PIK3CA gene that are not inherited, but occur in the body
cells as the baby develops (post-zygotic mutations). Symptoms of the following
disorders can be similar to those of MCAP syndrome. Comparisons may be useful
for a differential diagnosis.
Cutis marmorata telangiectatica congenita
(CMTC) is a rare type of vascular malformation composed predominantly of
capillary and vein-sized vessels within the skin. The skin lesions are
characterized by a lace-like vascular pattern that are often pink-purple in
color and may involve a limited or more widespread area of the skin surface. As
a result, the skin has a purple or blue marbled or “fishnet” appearance
resembling cutis marmorata. In some affected individuals, thinning of the skin
(atrophy), breakdown (ulceration) or complete absence of the skin in affected
areas may also be present. A diagnosis of macrocephaly-capillary malformation
may be confirmed through a thorough clinical evaluation that includes a
detailed history and physical examination looking for MCAP-associated features.
Molecular diagnosis requires demonstration of a mosaic activating mutation in
PIK3CA, which may require advanced genetic testing to be performed on affected
tissues (e.g. skin fibroblasts) or samples other than blood. Different
diagnostic criteria have been proposed in the medial literature. Hydrocephalus
and cerebellar tonsillar ectopia warrant immediate attention and referral to a
neurosurgeon. Rapidly progressive hydrocephalus may require neurosurgical
shunting and experience suggests that some patients benefit from a
minimally-invasive 4th ventriculostomy. The guidelines for the management of
cerebellar tonsillar ectopia are less clear. However surgical management
(posterior fossa decompression) should be considered on a case-by-case basis
and discussed with the neurologist and neurosurgeon involved in the child’s
care. Seizures, if present, should be managed by a neurologist. There is no
definite treatment for this syndrome and all clinical measures are needed to
reduce the suffering of the sufferers. Genetic counseling is also important for
all parents who want a healthy baby [12].
1. Luks
VL, Kamitaki N, Vivero MP, Uller W, Rab R, et al. (2015) Lymphatic and other
vascular malformative/overgrowth disorders are caused by somatic mutations in
PIK3CA. J Pediatr 166: 1048-54.e1-5.
2. Martínez-Glez
V, Romanelli V, Mori MA, Gracia R, Segovia M, et al. (2010)
Macrocephaly-capillary malformation: Analysis of 13 patients and review of the
diagnostic criteria. Am J Med Genet A 152A: 3101-3106.
3. Mirzaa
GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, et al. (2012)
Megalencephaly-capillary malformation (MCAP) and
megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: Two
closely related disorders of brain overgrowth and abnormal brain and body
morphogenesis. Am J Med Genet A 158A: 269-291.
4. Mirzaa
GM, Rivière JB, Dobyns WB (2013) Megalencephaly syndromes and activating
mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med
Genet 163C: 122-130.
5. Rivière
JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, et al. (2012) De novo
germline and post zygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum
of related megalencephaly syndromes. Nat Genet 44: 934-940.
6. Giulino
F, David A, Edery P, Sigaudy S, Bonneau D, et al. (2004) Macrocephaly-cutis
marmorata telangiectatica congenita: Seven cases including two with unusual
cerebral manifestations. Am J Med Genet A 126: 99-103.
7. Magarbane
A, Haddad J, Lyonnet S, Clayton-Smith J (2003) Child with overgrowth,
pigmentary streaks, polydactyly and intestinal lymphangiectasia:
macrocephaly-cutis marmorata telangiectatica congenita syndrome or new
disorder. Am J Med Genet A 116: 184-187.
8. Toriello
HV, Mulliken JB (2007) Accurately renaming macrocephaly-cutis marmorata
telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation
(M-CM). Am J Med Genet A 143A: 3009.
9. Conway
RL, Pressman BD, Dobyns WB, Danielpour M, Lee J, et al. (2007) Neuroimaging
findings in macrocephaly-capillary malformation: A longitudinal study of 17
patients. Am J Med Genet A 143A: 2981-3008.
10. Gonzalez
ME, Burk CJ, Barbouth DS, Connelly EA (2009) Macrocephaly-capillary
malformation: A report of three cases and review of the literature. Pediatr
Dermatol 26: 342-346.
11. Wright
DR, Friedan IJ, Orlow SJ, Shin HT, Chamlin S, et al. (2009) The misnomer
“macrocephaly-cutis marmorata telangiectasia congenital syndrome.” Report of 12
new cases and support for revising the name to macrocephaly-capillary malformation.
Arch Dermatol 145: 287-293.
12. Martinez-Glez
V, Romanelli V, Mori MA, Gracia R, Segovia M, et al. (2010)
Macrocephaly-capillary malformation: Analysis of 13 patients and review of the
diagnostic criteria. Am J Med Genet 152A: 3102-3106.
QUICK LINKS
- SUBMIT MANUSCRIPT
- RECOMMEND THE JOURNAL
-
SUBSCRIBE FOR ALERTS
RELATED JOURNALS
- Food and Nutrition-Current Research (ISSN:2638-1095)
- Journal of Womens Health and Safety Research (ISSN:2577-1388)
- Journal of Agriculture and Forest Meteorology Research (ISSN:2642-0449)
- Journal of Astronomy and Space Research
- Advances in Nanomedicine and Nanotechnology Research (ISSN: 2688-5476)
- Journal of Microbiology and Microbial Infections (ISSN: 2689-7660)
- Journal of Genomic Medicine and Pharmacogenomics (ISSN:2474-4670)